Display options
Share it on

Oncol Rev. 2013 Dec 02;7(1):e8. doi: 10.4081/oncol.2013.e8. eCollection 2013 Apr 22.

The Role of microRNAs in Stemness of Cancer Stem Cells.

Oncology reviews

Seyed Mohammad Ali Hosseini Rad, Mahsa Shanaki Bavarsad, Ehsan Arefian, Kaveh Jaseb, Mohammad Shahjahani, Najmaldin Saki

Affiliations

  1. Department of Molecular Biology and Genetic Engineering, Stem Cell Technology Research Center , Tehran ; Department of Virology, Faculty of Medical Sciences, Tarbiat Modares University , Tehran.
  2. Health Research Center, Research Institute of Thalassemia and Hemoglobinopathy, Ahvaz Jundishapur University of Medical Sciences , Ahvaz.
  3. Department of Molecular Biology and Genetic Engineering, Stem Cell Technology Research Center , Tehran ; Department of Microbiology, School of Biology, College of Science, University of Tehran , Tehran, Iran.
  4. Department of Virology, Faculty of Medical Sciences, Tarbiat Modares University , Tehran.
  5. Department of Molecular Biology and Genetic Engineering, Stem Cell Technology Research Center , Tehran ; Health Research Center, Research Institute of Thalassemia and Hemoglobinopathy, Ahvaz Jundishapur University of Medical Sciences , Ahvaz.

PMID: 25992229 PMCID: PMC4419617 DOI: 10.4081/oncol.2013.e8

Abstract

Cancer is one of the most important diseases of humans, for which no cure has been found so far. Understanding the causes of cancer can pave the way for its treatment. Alteration in genetic elements such as oncogenes and tumor suppressor genes results in cancer. The most recent theory for the origin of cancer has been provided by cancer stem cells (CSCs). Tumor-initiating cells (T-ICs) or CSCs are a small population isolated from tumors and hematologic malignancies. Since CSCs are similar to embryonic stem cells (ESCs) in many aspects (such as pluripotency and self-renewal), recognizing the signaling pathways through which ESCs maintain their stemness can also help identify CSC signaling. One component of these signaling pathways is non-coding RNAs (ncRNAs). ncRNAs are classified in two groups: microRNAs (miRNAs) and long non-coding RNAs (lncRNAs). miRNAs undergo altered expression in cancer. In this regard, they are classified as Onco-miRNAs or tumor suppressor miRNAs. Some miRNAs play similar roles in ESCs and CSCs, such as let-7 and miR-302. This review focuses on the miRNAs involved in stemness of ESCs and CSCs by presenting a summary of the role of miRNAs in other tumor cells.

Keywords: cancer; cancer stem cells; embryonic stem cells; microRNAs; stemness

References

  1. Stem Cells. 2009 Jul;27(7):1524-8 - PubMed
  2. Cell. 2009 Aug 7;138(3):592-603 - PubMed
  3. Nat Chem Biol. 2007 Mar;3(3):136-7 - PubMed
  4. Oncogene. 2010 Jul 22;29(29):4194-204 - PubMed
  5. Trends Cell Biol. 2005 Sep;15(9):494-501 - PubMed
  6. Cancer Gene Ther. 2012 Nov;19(11):723-30 - PubMed
  7. Cell Death Dis. 2013 Feb 28;4:e514 - PubMed
  8. Breast Cancer Res. 2004;6(6):R605-15 - PubMed
  9. Nat Rev Drug Discov. 2008 Sep;7(9):771-82 - PubMed
  10. Cell. 2005 Sep 23;122(6):947-56 - PubMed
  11. Oncogene. 2011 May 26;30(21):2463-74 - PubMed
  12. Proc Natl Acad Sci U S A. 2004 Mar 2;101(9):2999-3004 - PubMed
  13. Nat Biotechnol. 2009 May;27(5):459-61 - PubMed
  14. Nat Rev Genet. 2013 Jun;14(6):427-39 - PubMed
  15. Cell. 2005 Mar 11;120(5):635-47 - PubMed
  16. Proc Natl Acad Sci U S A. 2007 Jun 12;104(24):10158-63 - PubMed
  17. Cancer Res. 2007 Feb 15;67(4):1419-23 - PubMed
  18. Cancer Res. 2004 Jun 1;64(11):3753-6 - PubMed
  19. Nature. 2005 Jun 9;435(7043):839-43 - PubMed
  20. Carcinogenesis. 2012 Jan;33(1):68-76 - PubMed
  21. Nat Rev Mol Cell Biol. 2009 Feb;10(2):116-25 - PubMed
  22. Genes Dev. 2007 May 1;21(9):1025-30 - PubMed
  23. Cancer Res. 2006 Oct 1;66(19):9339-44 - PubMed
  24. Cell Cycle. 2007 Jul 1;6(13):1586-93 - PubMed
  25. EMBO Rep. 2008 Jun;9(6):582-9 - PubMed
  26. Cancer Res. 2006 Jun 15;66(12 ):6063-71 - PubMed
  27. Nature. 2005 Jun 9;435(7043):828-33 - PubMed
  28. Cancer Res. 2008 Nov 15;68(22):9125-30 - PubMed
  29. Dev Cell. 2008 Jun;14(6):818-29 - PubMed
  30. Cell Stem Cell. 2013 May 2;12(5):602-15 - PubMed
  31. Cancers (Basel). 2011 Feb 21;3(1):716-29 - PubMed
  32. Nat Med. 2011 Feb;17(2):211-5 - PubMed
  33. Stem Cells. 2012 Oct;30(10 ):2076-87 - PubMed
  34. Carcinogenesis. 2011 May;32(5):772-8 - PubMed
  35. Mol Cell. 2012 Sep 28;47(6):827-38 - PubMed
  36. Nat Rev Mol Cell Biol. 2007 Jan;8(1):23-36 - PubMed
  37. Br J Cancer. 2012 Mar 27;106(7):1320-30 - PubMed
  38. Int J Mol Sci. 2013 Jul 15;14(7):14712-23 - PubMed
  39. Nature. 1994 Feb 17;367(6464):645-8 - PubMed
  40. Mol Cancer Res. 2003 Oct;1(12):882-91 - PubMed
  41. Mol Cancer. 2011 Apr 13;10:38 - PubMed
  42. Nat Cell Biol. 2009 Dec;11(12 ):1487-95 - PubMed
  43. Nat Biotechnol. 2011 May;29(5):443-8 - PubMed
  44. EMBO J. 2009 Oct 21;28(20):3157-70 - PubMed
  45. Nature. 2007 Jan 4;445(7123):106-10 - PubMed
  46. Cell. 2007 Dec 14;131(6):1109-23 - PubMed
  47. Wiley Interdiscip Rev RNA. 2011 Sep-Oct;2(5):748-60 - PubMed
  48. PLoS One. 2012;7(11):e48699 - PubMed
  49. Nat Rev Mol Cell Biol. 2008 Jan;9(1):11-21 - PubMed
  50. Annu Rev Cell Dev Biol. 2013;29:213-39 - PubMed
  51. Cancer Res. 2007 Oct 15;67(20):9762-70 - PubMed
  52. PLoS One. 2012;7(7):e40849 - PubMed
  53. Stem Cell Rev. 2007 Jun;3(2):169-75 - PubMed
  54. Nat Genet. 2008 Dec;40(12):1478-83 - PubMed
  55. Oncogene. 2008 Sep 4;27(39):5204-13 - PubMed
  56. Proc Natl Acad Sci U S A. 2002 Nov 26;99(24):15524-9 - PubMed
  57. Oncogene. 2007 Jul 26;26(34):5017-22 - PubMed
  58. Mol Cell. 2007 Jun 8;26(5):731-43 - PubMed
  59. Cell Cycle. 2007 Nov 1;6(21):2585-90 - PubMed
  60. Cancer Cell. 2010 Nov 16;18(5):472-84 - PubMed
  61. Cell. 1993 Dec 3;75(5):843-54 - PubMed
  62. RNA. 2008 Oct;14(10):2115-24 - PubMed
  63. Oncogene. 2014 Jan 16;33(3):269-78 - PubMed
  64. Dev Cell. 2003 Aug;5(2):351-8 - PubMed
  65. EMBO J. 2011 Feb 16;30(4):756-69 - PubMed
  66. Cell Stem Cell. 2010 Dec 3;7(6):694-707 - PubMed
  67. Crit Rev Oncol Hematol. 2004 Jul;51(1):1-28 - PubMed
  68. Biochem Biophys Res Commun. 2008 Dec 12;377(2):668-73 - PubMed
  69. Oncogene. 2012 Dec 13;31(50):5162-71 - PubMed
  70. Cell Stem Cell. 2013 Jul 3;13(1):87-101 - PubMed
  71. Cancer Res. 2006 Dec 15;66(24):11590-3 - PubMed
  72. Cell. 2008 Aug 8;134(3):521-33 - PubMed
  73. Nat Rev Cancer. 2008 May;8(5):387-98 - PubMed
  74. Nature. 2004 Nov 18;432(7015):396-401 - PubMed
  75. Nucleic Acids Res. 2012 Feb;40(4):1695-707 - PubMed
  76. Cell Stem Cell. 2011 Dec 2;9(6):575-87 - PubMed
  77. Annu Rev Cell Dev Biol. 2007;23:675-99 - PubMed
  78. J Clin Invest. 2012 Nov;122(11):4077-93 - PubMed
  79. Nucleic Acids Res. 2005 Sep 28;33(17):5394-403 - PubMed
  80. Cell Stem Cell. 2011 Feb 4;8(2):164-76 - PubMed
  81. Clin Cancer Res. 2005 Feb 1;11(3):1119-28 - PubMed
  82. Nat Rev Cancer. 2006 Nov;6(11):857-66 - PubMed
  83. Cancer Res. 2008 Apr 1;68(7):2094-105 - PubMed
  84. Nat Cell Biol. 2005 Feb;7(2):165-71 - PubMed
  85. Stem Cell Rev. 2005;1(3):197-205 - PubMed
  86. Nat Cell Biol. 2008 May;10 (5):593-601 - PubMed
  87. Cancer Res. 2005 Aug 15;65(16):7065-70 - PubMed
  88. Nature. 2008 Oct 23;455(7216):1124-8 - PubMed
  89. IDrugs. 2009 Aug;12(8):492-6 - PubMed
  90. Nat Cell Biol. 2011 Mar;13(3):317-23 - PubMed
  91. Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):3983-8 - PubMed
  92. Proc Natl Acad Sci U S A. 2005 Sep 27;102(39):13944-9 - PubMed
  93. Annu Rev Biomed Eng. 2011 Aug 15;13:507-30 - PubMed
  94. Carcinogenesis. 2005 Feb;26(2):495-502 - PubMed
  95. Cell. 2013 Jul 18;154(2):311-24 - PubMed
  96. Oncogene. 2006 Mar 16;25(12):1696-708 - PubMed
  97. Trends Biochem Sci. 2009 Oct;34(10):491-9 - PubMed
  98. Cell. 2012 Dec 21;151(7):1617-32 - PubMed
  99. Cancer Res. 2011 Jan 1;71(1):3-7 - PubMed
  100. Oncogene. 2007 Jun 28;26(30):4442-52 - PubMed
  101. PLoS One. 2010 May 14;5(5):e10563 - PubMed
  102. EMBO J. 2011 Aug 19;30(20):4309-22 - PubMed
  103. Cell. 2010 Aug 6;142(3):409-19 - PubMed
  104. Oncogene. 2014 May 15;33(20):2589-600 - PubMed
  105. Hum Mol Genet. 2010 Oct 15;19(R2):R152-61 - PubMed

Publication Types